Loading…
Loading…
YIHCF (YiChang HEC ChangJiang Pharmaceutical Co., Ltd.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for YIHCF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for YIHCF and 80,000+ other tickers.
See exactly how YIHCF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for YIHCF and 80,000+ other tickers.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise primarily engaged in the development, manufacturing, and distribution of medicinal products. Operating within the People's Republic of China, its therapeutic expertise spans antiviral treatments, solutions for endocrine and metabolic disorders, and cardiovascular health. In addition to finished pharmaceuticals, the company produces and markets active pharmaceutical ingredients (APIs) and dedicates resources to the research and development of medical devices, novel drugs, and biotechnology. It also extends…
No recent news available.